Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$276M |
| 2 |
IBM
IBM
|
+$272M |
| 3 |
Procter & Gamble
PG
|
+$161M |
| 4 |
Colgate-Palmolive
CL
|
+$151M |
| 5 |
BBBY
Bed Bath & Beyond Inc
BBBY
|
+$146M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Verizon
VZ
|
+$405M |
| 2 |
CELG
Celgene Corp
CELG
|
+$207M |
| 3 |
Booking.com
BKNG
|
+$123M |
| 4 |
Eli Lilly
LLY
|
+$114M |
| 5 |
BEAM
BEAM INC COM STK (DE)
BEAM
|
+$109M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.92% |
| 2 | Healthcare | 13.46% |
| 3 | Consumer Discretionary | 11.99% |
| 4 | Industrials | 10.52% |
| 5 | Consumer Staples | 9.55% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
PARA
201
DELISTED
Paramount Global Class B
PARA
| $48.6M | 0.11% |
782,500
-268,388
| -26% | -$16M |
|
202
Ulta Beauty
ULTA
$23.3B
| $47.4M | 0.11% |
+518,300
| New | +$46.7M |
|
203
Bio-Techne
TECH
$11.2B
| $47.2M | 0.11% |
2,040,400
-270,400
| -12% | -$5.98M |
|
|
SPWR
204
DELISTED
SunPower Corporation Common Stock
SPWR
| $47M | 0.11% |
+1,752,741
| New | +$38.4M |
|
|
SNI
205
DELISTED
Scripps Networks Interactive, Inc Common Class A
SNI
| $46.8M | 0.11% |
576,600
+101,550
| +21% | +$7.77M |
|
206
Warner Bros
WBD
$67.9B
| $46.6M | 0.11% |
1,228,311
+944,057
| +332% | +$37.1M |
|
|
UNS
207
DELISTED
UNS ENERGY CORP COM
UNS
| $46.4M | 0.11% |
768,100
-211
| -0% | -$12.7K |
|
208
Merck
MRK
$322B
| $46M | 0.11% |
833,720
+628,102
| +305% | +$34.3M |
|
|
LLL
209
DELISTED
L3 Technologies, Inc.
LLL
| $46M | 0.11% |
380,700
+261,737
| +220% | +$31.1M |
|
|
GGP
210
DELISTED
GGP Inc.
GGP
| $45.6M | 0.11% |
1,936,700
-1,022,086
| -35% | -$23.7M |
|
211
Omnicom Group
OMC
$23.6B
| $45.6M | 0.11% |
639,700
-112,200
| -15% | -$7.81M |
|
212
Bunge Global
BG
$21.4B
| $44.8M | 0.1% |
591,800
-5,233
| -0.9% | -$405K |
|
|
ETP
213
DELISTED
Energy Transfer Partners L.p.
ETP
| $44.1M | 0.1% |
760,213
-39,014
| -5% | -$2.19M |
|
|
BWLD
214
DELISTED
Buffalo Wild Wings, Inc.
BWLD
| $43.9M | 0.1% |
264,800
+18,405
| +7% | +$2.7M |
|
215
Dillards
DDS
$10.1B
| $43.7M | 0.1% |
375,000
-90,686
| -19% | -$9.47M |
|
216
Avery Dennison
AVY
$13.6B
| $43.6M | 0.1% |
850,200
-101,625
| -11% | -$5.04M |
|
217
Roper Technologies
ROP
$39.5B
| $43.6M | 0.1% |
298,400
+25,000
| +9% | +$3.49M |
|
|
QVCGA
218
DELISTED
QVC Group Inc Series A
QVCGA
| $43.2M | 0.1% |
35,799
+20,352
| +132% | +$24.3M |
|
|
VG
219
DELISTED
Vonage Holdings Corporation
VG
| $43M | 0.1% |
11,471,600
+94,782
| +0.8% | +$358K |
|
220
Bankunited
BKU
$3.35B
| $42.8M | 0.1% |
1,277,800
-96,926
| -7% | -$3.22M |
|
221
American Airlines Group
AAL
$10.1B
| $42.6M | 0.1% |
992,632
+1,700
| +0.2% | +$66.3K |
|
|
CELG
222
DELISTED
Celgene Corp
CELG
| $42.6M | 0.1% |
495,900
-2,717,760
| -85% | -$207M |
|
223
Jack in the Box
JACK
$341M
| $42.4M | 0.1% |
708,700
-104,500
| -13% | -$5.99M |
|
224
Euronet Worldwide
EEFT
$2.64B
| $42.2M | 0.1% |
874,100
+84,100
| +11% | +$3.82M |
|
|
HAR
225
DELISTED
Harman International Industries
HAR
| $42M | 0.1% |
391,000
+149,300
| +62% | +$15.9M |
|
Similar funds
Jim Simons's Q2 2014 Portfolio in Review
As of Q2 2014, Jim Simons held 3,246 positions worth $42.9B, up 2.9% from $41.7B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Jim Simons's Q2 2014 filing shows 450 new, 1,273 increased, 1,008 reduced and 492 closed positions. Its largest new stake was Procter & Gamble: 2,001,729 shares worth $157M. The largest sale was Verizon, an estimated $405M.
By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 15% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Jim Simons's largest Q2 2014 buy was Procter & Gamble: 2,001,729 shares worth $157M.
- Jim Simons added most to Pfizer in Q2 2014, an estimated $276M increase.
- Jim Simons's biggest Q2 2014 reduction was Verizon, cutting an estimated $405M.
- Jim Simons fully exited Booking.com in Q2 2014, selling an estimated $123M.
- Jim Simons's ten largest holdings make up 14% of its $42.9B portfolio in Q2 2014.
- Jim Simons opened 450 new positions and closed 492 in Q2 2014.
- Jim Simons's portfolio value rose 2.9% quarter-over-quarter to $42.9B.
Based on Renaissance Technologies's 13F filing for Q2 2014, filed 13 Aug 2014.